Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 03, 2026 1 hour, 59 minutes ago
Medical News: A growing body of research is shedding new light on how the chikungunya virus is not just a short-term illness but a long-term health threat capable of triggering chronic arthritis that can last for years. Scientists are now racing to better understand the virus and develop vaccines that could prevent future outbreaks and long-term complications.
Chikungunya virus may cause long-term joint damage while new vaccines offer hope for prevention
A Mosquito Virus with Lasting Impact
Chikungunya is a virus spread by mosquito bites, particularly from Aedes species. While many people recover from the initial infection within days, a significant number go on to suffer persistent joint pain that mimics rheumatoid arthritis. This condition can severely affect quality of life, especially in older adults.
Researchers from the Yunnan Provincial Key Laboratory of Pharmacology for Natural Products at Kunming Medical University, the Medical School of Kunming University of Science and Technology, and the Institute of Medical Biology at the Chinese Academy of Medical Sciences and Peking Union Medical College have conducted an extensive review of the disease. Their findings highlight how the virus continues to affect patients long after the initial infection has cleared.
How the Virus Attacks the Body
Once inside the body, the chikungunya virus rapidly multiplies using the host’s own cellular machinery. It carries genetic material that allows it to hijack human cells and produce viral proteins. These proteins help the virus replicate and spread throughout the body.
The infection typically begins with high fever, rash, and severe joint pain. While the fever subsides quickly, joint pain can linger. This happens because the virus can remain in joint tissues, continuing to trigger inflammation even after the main infection has passed.
Why Joint Pain Becomes Chronic
One of the most important discoveries is that the virus can persist in the body, especially in joint tissues. This ongoing presence keeps the immune system activated, leading to continuous inflammation.
The study covered in this
Medical News report highlights that immune cells release inflammatory chemicals such as IL-1β, IL-6, and IL-17, which play a central role in sustaining joint damage. Over time, this inflammation can resemble autoimmune diseases, where the body mistakenly attacks its own tissues.
Scientists also found that nerve-related mechanisms may be involved. Some patients experience burning or stabbing pain, suggesting that the virus may affect nerve signaling as well. In addition, genetic factors appear to influence who develops chronic symptoms, making some individuals more vulnerable than others.
A Complex Web of Immune Reactions
The disease is driven by a combination of immune responses. Early in infection, the body produces interferons to fight the virus. However, chikungunya has evolved ways to block
these defenses, allowing it to persist.
At the same time, immune cells such as T-cells infiltrate joint tissues, prolonging inflammation. Studies also show that regulatory immune functions may be weakened, reducing the body’s ability to control excessive inflammation.
This combination of viral persistence, immune overreaction, and possible autoimmune effects creates a cycle that leads to long-term joint damage.
Progress in Vaccine Development
Despite the lack of specific antiviral treatments, there is encouraging progress in vaccine development. Two vaccines have already been approved, including a live attenuated vaccine and another based on virus-like particles.
These vaccines have shown strong immune responses and good safety profiles in clinical trials. Newer approaches, including mRNA and viral vector vaccines, are also being tested and show promising results in early studies.
The goal is not only to prevent infection but also to reduce the risk of chronic complications that can follow.
Global Spread Raises Concerns
The chikungunya virus has spread rapidly across continents due to globalization, climate change, and the expanding range of mosquito vectors. Mutations in the virus have made it more efficient at spreading, increasing the risk of large outbreaks.
Recent outbreaks have demonstrated how quickly the virus can move through populations, emphasizing the need for better surveillance and prevention strategies.
Conclusion
Chikungunya is no longer just an acute viral illness but a complex disease with long-term consequences. The ability of the virus to persist in joint tissues, trigger prolonged immune responses, and interact with genetic and neurological factors makes it particularly challenging to manage. Continued research into its mechanisms and the development of effective vaccines and treatments will be essential to reduce its growing global health burden and prevent chronic suffering among affected patients.
The study findings were published in the peer reviewed journal: Viruses.
https://www.mdpi.com/1999-4915/18/4/428
For the latest on the Chikungunya virus, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/new-viral-blocking-compound-derived-from-the-phytochemical-coumarin-shows-promise-against-chikungunya-virus
https://www.thailandmedical.news/news/spirulina-algae-shows-powerful-effects-against-chikungunya-virus
https://www.thailandmedical.news/news/chikungunya-infection-can-cause-rare-immune-blood-disorder
Share
Tweet
Share
